FOXO4-DRI is a synthetic, rationally designed senolytic peptide. It was developed to selectively induce apoptosis in senescent cells, which are cells that have entered a…

A mitochondria-targeting tetrapeptide that became the first FDA-approved mitochondrial-targeted therapeutic when it received accelerated approval as Forzinity in September 2025 for Barth syndrome — an…

Humanin is a 24-amino acid, cytoprotective peptide encoded by the mitochondrial genome. It was first discovered in 2001 by Nishimoto and colleagues during a search…

A small synthetic angiotensin IV analog promoted in cognitive-enhancement and biohacker contexts as "300x more potent than BDNF."

⊘ Insufficient evidence

Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson and colleagues. It was designed as a simplified, more stable…